73 related articles for article (PubMed ID: 12759968)
1. [No switch region is found in the regulatory sequence of HPV 16 for promoter P97].
Dong X; Liu H; Pfister H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):325-7. PubMed ID: 12759968
[TBL] [Abstract][Full Text] [Related]
2. [YY1 and its repressive effect on human papillomavirus 16 early promoter P97 existed widely among human epithelial cell lines].
Dong X; Liu H; Pfister H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Sep; 12(3):217-22. PubMed ID: 12526319
[TBL] [Abstract][Full Text] [Related]
3. [Removal of YY1 binding sites in HPV 16 LCR increases viral transforming activities on mouse fibroblasts].
Dong X; Liu H; Pfister H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):5-8. PubMed ID: 12759941
[TBL] [Abstract][Full Text] [Related]
4. Different P105 promoter activities among natural variants of human papillomavirus type 18.
Sichero L; Franco EL; Villa LL
J Infect Dis; 2005 Mar; 191(5):739-42. PubMed ID: 15688288
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of human papillomavirus type 18 P105 promoter by the co-activator CBP.
Valencia-Hernández A; Cuevas-Bennett C; Garrido E
Intervirology; 2007; 50(6):418-25. PubMed ID: 18182775
[TBL] [Abstract][Full Text] [Related]
6. HPV-2 isolates from patients with huge verrucae vulgaris possess stronger promoter activities.
Lei YJ; Wang C; Gao C; Jiang HY; Chen JM; Han J; Yuan YK; Dong XP
Intervirology; 2007; 50(5):353-60. PubMed ID: 17728546
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers.
Dong XP; Stubenrauch F; Beyer-Finkler E; Pfister H
Int J Cancer; 1994 Sep; 58(6):803-8. PubMed ID: 7927871
[TBL] [Abstract][Full Text] [Related]
8. A transcriptional initiator overlaps with a conserved YY1 binding site in the long control region of human papillomavirus type 16.
Tan SH; Baker CC; Stünkel W; Bernard HU
Virology; 2003 Jan; 305(2):486-501. PubMed ID: 12573593
[TBL] [Abstract][Full Text] [Related]
9. Sequence variation and the transcriptional activity of the upstream regulatory region in human papillomavirus 16 E7 variants in cervical cancer of Korean women.
Kim YB; Song YS; Jeon YT; Park JS; Um SJ; Kim JW; Park NH; Kang SB; Lee HP
Oncol Rep; 2005 Aug; 14(2):459-64. PubMed ID: 16012730
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences.
Chen Z; Storthz KA; Shillitoe EJ
Cancer Res; 1997 Apr; 57(8):1614-9. PubMed ID: 9108468
[TBL] [Abstract][Full Text] [Related]
11. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation.
Badal S; Badal V; Calleja-Macias IE; Kalantari M; Chuang LS; Li BF; Bernard HU
Virology; 2004 Jul; 324(2):483-92. PubMed ID: 15207633
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin.
Mistry N; Simonsson M; Evander M
Virol J; 2007 Mar; 4():27. PubMed ID: 17352804
[TBL] [Abstract][Full Text] [Related]
13. Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers.
Rose BR; Thompson CH; Zhang J; Stoeter M; Stephen A; Pfister H; Tattersall MH; Cossart YE
Gynecol Oncol; 1997 Aug; 66(2):282-9. PubMed ID: 9264577
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a promoter in the E7 open reading frame of human papillomavirus type 11.
Tomita Y; Shiga T; Simizu B
Virology; 1996 Nov; 225(2):267-73. PubMed ID: 8918912
[TBL] [Abstract][Full Text] [Related]
15. Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter.
Murvai M; Borbély AA; Kónya J; Gergely L; Veress G
Arch Virol; 2004 Dec; 149(12):2379-92. PubMed ID: 15290353
[TBL] [Abstract][Full Text] [Related]
16. Detection of silencer activity in the long control regions of human papillomavirus type 6 isolated from both benign and malignant lesions.
Farr A; Pattison S; Youn BS; Roman A
J Gen Virol; 1995 Apr; 76 ( Pt 4)():827-35. PubMed ID: 9049328
[TBL] [Abstract][Full Text] [Related]
17. Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16.
Dong XP; Pfister H
J Gen Virol; 1999 Aug; 80 ( Pt 8)():2097-2101. PubMed ID: 10466808
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region.
Yasumoto S; Taniguchi A; Sohma K
J Virol; 1991 Apr; 65(4):2000-9. PubMed ID: 1848315
[TBL] [Abstract][Full Text] [Related]
19. A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter.
Bauknecht T; Jundt F; Herr I; Oehler T; Delius H; Shi Y; Angel P; Zur Hausen H
J Virol; 1995 Jan; 69(1):1-12. PubMed ID: 7983700
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional control of human papillomavirus type 18 oncogene expression in different cell lines: role of transcription factor YY1.
Jundt F; Herr I; Angel P; Zur Hausen H; Bauknecht T
Virus Genes; 1995; 11(1):53-8. PubMed ID: 8808335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
